Celldex Therapeutics shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $796k | 23k | 33.99 |
| 2024-06-30 | $867k | 23k | 37.01 |
| 2024-03-31 | $7.5M | 178k | 41.97 |
| 2023-09-30 | $2.5M | 92k | 27.52 |
| 2023-06-30 | $3.1M | 92k | 33.93 |
| 2023-03-31 | $3.3M | 92k | 35.98 |
| 2022-12-31 | $4.1M | 92k | 44.57 |
| 2022-09-30 | $301k | 11k | 28.10 |
| 2022-06-30 | $289k | 11k | 26.98 |
| 2022-03-31 | $365k | 11k | 34.08 |
| 2021-12-31 | $414k | 11k | 38.66 |